4KANTARJIAN H, O BRIEN S, CORTES J, et al. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastie syndrome: predictive prognostic models for outcome[J]. Cancer,2006,106 (5):1090-1098.
二级参考文献10
1Appelbaum FR, Gundacker H, Head DR, et al. Age and acute myeloid leukemia. Blood, 2006, 107(9) :3481-3485.
2Craig CM, Schiller GJ. Acute myeloid leukemia in the elderly: Conventional and novel treatment approaches. Blood Reviews, 2008, 22(4): 221-234.
3Menzin J, Lang K, Earle CC, et al. The outcome and costs of acute myeloid leukemia. Arch Intern Med, 2002, 162(14):1597-603.
4Larson RA, Stone RM, Mayer RJ, et al. Fifty years of clinical research by the Leukemia Committee of the Cancer and Leukemia GroupB. ClinCancerRes, 2006,12(11Pt 2):3556s-3563s.
5John PR, Yin JA. Prognostic factors in elderly patients with acute myeloid leukemia. Leuk Lymphoma, 1994,16(1-2): 51-56.
6Jehn U, Suciu S, Thomas X, et al. Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trial. Leukemia, 2006,20(10) : 1723-1730.
7Kantarjian H, O' Brien S, Cortes J, et al. Results of Intensive Chemotherapy in 998 Patients Age 65 Years or Older with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome. Cancer, 2006, 106(6) :1090-1098.
8Latagliata R, Bongarzoni V, Carmosino I, et al. Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy: the dark side of the moon. Ann Oncol, 2006, 17 (2) :281-285.
9Burnett AK, Milligan D, Prentice AG, et al. A Comparison of Low-Dose Cytarabine and Hydroxyurea With or Without All-trans Retinoic Acid for Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome in Patients Not Considered Fit for Intensive Treatment. Cancer,2007,109(6) : 1114-1124.
8Deschler B,de W itte T, M ertels mann R, et al. Treatment decision-making for older patients with high-risk myelodys-plastic syndrome or acute myeloid leukemia problems and approaches[J].Hematologica,2006,91( 11 ) : 1513-1522.
9Larson RA, Boogaerts M A, Estey E, et ol. Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relap seusing Mylotarg (gemtuzumab ozogamicin) [J]. Leukemia, 2002,16: 1627-1636.
